WNK1 Activates SGK1 to Regulate the Epithelial Sodium Channel

WNK (with no lysine [K]) kinases are serine-threonine protein kinases with an atypical placement of the catalytic lysine. Intronic deletions increase the expression of WNK1 in humans and cause pseudohypoaldosteronism type II, a form of hypertension. WNKs have been linked to ion carriers, but the und...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 102; no. 29; pp. 10315 - 10320
Main Authors Bing-e Xu, Stippec, Steve, Chu, Po-Yin, Lazrak, Ahmed, Li, Xin-Ji, Lee, Byung-Hoon, English, Jessie M., Ortega, Bernardo, Huang, Chou-Long, Cobb, Melanie H., Garbers, David L.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 19.07.2005
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:WNK (with no lysine [K]) kinases are serine-threonine protein kinases with an atypical placement of the catalytic lysine. Intronic deletions increase the expression of WNK1 in humans and cause pseudohypoaldosteronism type II, a form of hypertension. WNKs have been linked to ion carriers, but the underlying regulatory mechanisms are unknown. Here, we report a mechanism for the control of ion permeability by WNK1. We show that WNK1 activates the serum- and glucocorticoid-inducible protein kinase SGK1, leading to activation of the epithelial sodium channel. Increased channel activity induced by WNK1 depends on SGK1 and the E3 ubiquitin ligase Nedd4-2. This finding provides compelling evidence that this molecular mechanism contributes to the pathogenesis of hypertension in pseudohypoaldosteronism type II caused by WNK1 and, possibly, in other forms of hypertension.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Communicated by David L. Garbers, University of Texas Southwestern Medical Center, Dallas, TX, May 27, 2005
Author contributions: B.-e.X., C.-L.H., and M.H.C. designed research; B.-e.X., S.S., P.-Y.C., A.L., X.-J.L., B.-H.L., J.M.E., and B.O. performed research; B.-e.X., S.S., P.-Y.C., A.L., X.-J.L., B.-H.L., J.M.E., B.O., C.-L.H., and M.H.C. analyzed data; and B.-e.X., C.-L.H., and M.H.C. wrote the paper.
Abbreviations: CHO, Chinese hamster ovary; ENaC, epithelial sodium channel; KD, kinase-dead; NCC, sodium chloride cotransporter; PHA II, pseudohypoaldosteronism type II.
To whom correspondence may be addressed. E-mail: melanie.cobb@utsouthwestern.edu or chou-long.huang@utsouthwestern.edu.
Present address: Pfizer Research and Technology, 620 Memorial Drive, Cambridge, MA 02139.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0504422102